Cargando…
High-density lipoprotein proteome dynamics in human endotoxemia
BACKGROUND: A large variety of proteins involved in inflammation, coagulation, lipid-oxidation and lipid metabolism have been associated with high-density lipoprotein (HDL) and it is anticipated that changes in the HDL proteome have implications for the multiple functions of HDL. Here, SELDI-TOF mas...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146904/ https://www.ncbi.nlm.nih.gov/pubmed/21711511 http://dx.doi.org/10.1186/1477-5956-9-34 |
_version_ | 1782209261141491712 |
---|---|
author | Levels, Johannes HM Geurts, Pierre Karlsson, Helen Marée, Raphaël Ljunggren, Stefan Fornander, Louise Wehenkel, Louis Lindahl, Mats Stroes, Erik SG Kuivenhoven, Jan A Meijers, Joost CM |
author_facet | Levels, Johannes HM Geurts, Pierre Karlsson, Helen Marée, Raphaël Ljunggren, Stefan Fornander, Louise Wehenkel, Louis Lindahl, Mats Stroes, Erik SG Kuivenhoven, Jan A Meijers, Joost CM |
author_sort | Levels, Johannes HM |
collection | PubMed |
description | BACKGROUND: A large variety of proteins involved in inflammation, coagulation, lipid-oxidation and lipid metabolism have been associated with high-density lipoprotein (HDL) and it is anticipated that changes in the HDL proteome have implications for the multiple functions of HDL. Here, SELDI-TOF mass spectrometry (MS) was used to study the dynamic changes of HDL protein composition in a human experimental low-dose endotoxemia model. Ten healthy men with low HDL cholesterol (0.7+/-0.1 mmol/L) and 10 men with high HDL cholesterol levels (1.9+/-0.4 mmol/L) were challenged with endotoxin (LPS) intravenously (1 ng/kg bodyweight). We previously showed that subjects with low HDL cholesterol are more susceptible to an inflammatory challenge. The current study tested the hypothesis that this discrepancy may be related to differences in the HDL proteome. RESULTS: Plasma drawn at 7 time-points over a 24 hour time period after LPS challenge was used for direct capture of HDL using antibodies against apolipoprotein A-I followed by subsequent SELDI-TOF MS profiling. Upon LPS administration, profound changes in 21 markers (adjusted p-value < 0.05) were observed in the proteome in both study groups. These changes were observed 1 hour after LPS infusion and sustained up to 24 hours, but unexpectedly were not different between the 2 study groups. Hierarchical clustering of the protein spectra at all time points of all individuals revealed 3 distinct clusters, which were largely independent of baseline HDL cholesterol levels but correlated with paraoxonase 1 activity. The acute phase protein serum amyloid A-1/2 (SAA-1/2) was clearly upregulated after LPS infusion in both groups and comprised both native and N-terminal truncated variants that were identified by two-dimensional gel electrophoresis and mass spectrometry. Individuals of one of the clusters were distinguished by a lower SAA-1/2 response after LPS challenge and a delayed time-response of the truncated variants. CONCLUSIONS: This study shows that the semi-quantitative differences in the HDL proteome as assessed by SELDI-TOF MS cannot explain why subjects with low HDL cholesterol are more susceptible to a challenge with LPS than those with high HDL cholesterol. Instead the results indicate that hierarchical clustering could be useful to predict HDL functionality in acute phase responses towards LPS. |
format | Online Article Text |
id | pubmed-3146904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-31469042011-07-31 High-density lipoprotein proteome dynamics in human endotoxemia Levels, Johannes HM Geurts, Pierre Karlsson, Helen Marée, Raphaël Ljunggren, Stefan Fornander, Louise Wehenkel, Louis Lindahl, Mats Stroes, Erik SG Kuivenhoven, Jan A Meijers, Joost CM Proteome Sci Research BACKGROUND: A large variety of proteins involved in inflammation, coagulation, lipid-oxidation and lipid metabolism have been associated with high-density lipoprotein (HDL) and it is anticipated that changes in the HDL proteome have implications for the multiple functions of HDL. Here, SELDI-TOF mass spectrometry (MS) was used to study the dynamic changes of HDL protein composition in a human experimental low-dose endotoxemia model. Ten healthy men with low HDL cholesterol (0.7+/-0.1 mmol/L) and 10 men with high HDL cholesterol levels (1.9+/-0.4 mmol/L) were challenged with endotoxin (LPS) intravenously (1 ng/kg bodyweight). We previously showed that subjects with low HDL cholesterol are more susceptible to an inflammatory challenge. The current study tested the hypothesis that this discrepancy may be related to differences in the HDL proteome. RESULTS: Plasma drawn at 7 time-points over a 24 hour time period after LPS challenge was used for direct capture of HDL using antibodies against apolipoprotein A-I followed by subsequent SELDI-TOF MS profiling. Upon LPS administration, profound changes in 21 markers (adjusted p-value < 0.05) were observed in the proteome in both study groups. These changes were observed 1 hour after LPS infusion and sustained up to 24 hours, but unexpectedly were not different between the 2 study groups. Hierarchical clustering of the protein spectra at all time points of all individuals revealed 3 distinct clusters, which were largely independent of baseline HDL cholesterol levels but correlated with paraoxonase 1 activity. The acute phase protein serum amyloid A-1/2 (SAA-1/2) was clearly upregulated after LPS infusion in both groups and comprised both native and N-terminal truncated variants that were identified by two-dimensional gel electrophoresis and mass spectrometry. Individuals of one of the clusters were distinguished by a lower SAA-1/2 response after LPS challenge and a delayed time-response of the truncated variants. CONCLUSIONS: This study shows that the semi-quantitative differences in the HDL proteome as assessed by SELDI-TOF MS cannot explain why subjects with low HDL cholesterol are more susceptible to a challenge with LPS than those with high HDL cholesterol. Instead the results indicate that hierarchical clustering could be useful to predict HDL functionality in acute phase responses towards LPS. BioMed Central 2011-06-28 /pmc/articles/PMC3146904/ /pubmed/21711511 http://dx.doi.org/10.1186/1477-5956-9-34 Text en Copyright ©2011 Levels et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Levels, Johannes HM Geurts, Pierre Karlsson, Helen Marée, Raphaël Ljunggren, Stefan Fornander, Louise Wehenkel, Louis Lindahl, Mats Stroes, Erik SG Kuivenhoven, Jan A Meijers, Joost CM High-density lipoprotein proteome dynamics in human endotoxemia |
title | High-density lipoprotein proteome dynamics in human endotoxemia |
title_full | High-density lipoprotein proteome dynamics in human endotoxemia |
title_fullStr | High-density lipoprotein proteome dynamics in human endotoxemia |
title_full_unstemmed | High-density lipoprotein proteome dynamics in human endotoxemia |
title_short | High-density lipoprotein proteome dynamics in human endotoxemia |
title_sort | high-density lipoprotein proteome dynamics in human endotoxemia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3146904/ https://www.ncbi.nlm.nih.gov/pubmed/21711511 http://dx.doi.org/10.1186/1477-5956-9-34 |
work_keys_str_mv | AT levelsjohanneshm highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT geurtspierre highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT karlssonhelen highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT mareeraphael highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT ljunggrenstefan highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT fornanderlouise highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT wehenkellouis highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT lindahlmats highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT stroeseriksg highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT kuivenhovenjana highdensitylipoproteinproteomedynamicsinhumanendotoxemia AT meijersjoostcm highdensitylipoproteinproteomedynamicsinhumanendotoxemia |